Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

about

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

Item

http://www.wikidata.org/entity/Q58780538

description

scientific article published on 31 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

@en

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

@nl

type

Item

label

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

@en

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

@nl

prefLabel

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

@en

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

@nl

P1476

Late-Onset Post-radiation Lymphedema Provoked by Bee Venom Therapy: A Case Report

@en

P2093

Hyo Sik Park

http://www.w3.org/2001/XMLSchema#string

Jong Youb Lim

http://www.w3.org/2001/XMLSchema#string

Kang Jae Jung

http://www.w3.org/2001/XMLSchema#string

Shin Who Park

http://www.w3.org/2001/XMLSchema#string

Yong Sung Jeong

http://www.w3.org/2001/XMLSchema#string

Young Jae Seo

http://www.w3.org/2001/XMLSchema#string

P2860

Risk associated with bee venom therapy: a systematic review and meta-analysis

Immune thrombocytopenia after bee venom therapy: a case report.

Current Treatments for Breast Cancer-Related Lymphoedema: A Systematic Review

Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study.

Complications of pelvic lymph node dissection for prostate cancer.

Bee venom in cancer therapy.

Safety of essential bee venom pharmacopuncture as assessed in a randomized controlled double-blind trial.

Impact of Bee Venom Enzymes on Diseases and Immune Responses.

Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice.

P304

626-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.5535/ARM.2018.42.4.626

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ja Young Choi

P577

2018-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30180534

http://www.w3.org/2001/XMLSchema#string

P932

6129717

http://www.w3.org/2001/XMLSchema#string